Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy: Technical considerations based on experience at a single institution

Strahlentherapie und Onkologie

Volumn 189, Issue 8, 2013, Pages 656-663

  Mizumoto, M ^a   Okumura, T ^a   Ishikawa, E ^a   Yamamoto, T ^a   Takano, S ^a   Matsumura, A ^a   Oshiro, Y ^a   Ishikawa, H ^a   Sakurai, H ^a   Tsuboi, K ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

Author keywords

Glioblastoma; Proton beam therapy; Radiotherapy; Recurrent; Reirradiation

Indexed keywords

CISPLATIN; ETOPOSIDE; NIMUSTINE; STEROID; TEMOZOLOMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTRAST ENHANCEMENT; DERMATITIS; EPENDYMOMA; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HEADACHE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRESCHOOL CHILD; PROTON THERAPY; RADIATION DOSE; RADIATION NECROSIS; RECURRENT CANCER; REPEAT PROCEDURE; SCHOOL CHILD; STEROID THERAPY; SURVIVAL TIME; TERATOMA; TREATMENT DURATION; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTONS; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881255183     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0390-6     Document Type: Article

References (21)

1. (o A) 2010 CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004-2006.
2. Combs SE, Thilmann C, Edler L et al (2005) Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol 23:8863-8869
3. Combs SE, Widmer V, Thilmann C et al (2005) Stereotactic radiosurgery (SRS), treatment option for recurrent glioblastoma multiforme (GBM). Cancer 104:2168-2173
4. Fogh SE, Andrews DW, Glass J et al (2010) Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 28:3048-3053
5. Fokas E, Wacker U, Gross WG et al (2009) Hypofractionated stereotactic reirradiation of recurrent glioblastomas. Strahlenther Onkol 185:235-240
6. Kong DS, Lee JI, Park K et al (2008) Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer 112:2046-2051
7. Minniti G, Armosini V, Salvati M et al (2011) Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. J Neurooncol 103:683-691
8. Mayer R, Sminia P (2008) Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 70:1350-1360
9. Fukumitsu N, Okumura T, Mizumoto M et al (2012) Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam. Int J Radiat Oncol Biol Phys 83:704-711
10. Igaki H, Tokuuye K, Okumura T et al (2004) Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 60:1120-1126
11. Mizumoto M, Tsuboi K, Igaki H et al (2010) Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys 77:98-105
12. Mizumoto M, Okumura T, Hashimoto T et al (2011) Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 81:1039-1045
13. Oshiro Y, Mizumoto M, Okumura T et al (2012) Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III. J Thorac Oncol 7:370-375
14. Gerweck LE, Kozin SV (1999) Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol 50:135-142
15. Paganetti H, Niemierko A, Ancukiewicz M et al (2002) Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 53:407-421
16. Barendsen GW (1982) Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8:1981-1997
17. Joiner MC, Van der Kogel AJ (1997) The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel GG (Ed) Basic clinical radiobiology. Oxford University Press, New York, NY, S 106-112
18. Mizumoto M, Sugahara S, Nakayama H et al (2010) Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther Onkol 186:482-488
19. National Cancer Institute (2013) National Cancer Institute common toxicity criteria. http://ctep.cancer.gov/protocolDevelopment/electronic- applications/docs/ctcaev3.pdf. Accessed March 2013
20. Lorentini S, Amichetti M, Spiazzi L et al (2012) Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. Strahlenther Onkol 188:216-225
21. Holy R, Piroth M, Pinkawa M et al (2011) Stereotactic Body Radiation Therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 187:245-251